SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Depression drug developer NRX Pharmaceuticals' Q3 loss narrows

Depression drug developer NRX Pharmaceuticals' Q3 loss narrows Overview US biopharma firm reported Q

CNSPCUENRXPORIC

Related stories